Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
2.230
+0.040 (1.83%)
At close: Jan 17, 2025, 4:00 PM
2.200
-0.030 (-1.35%)
After-hours: Jan 17, 2025, 7:50 PM EST
Outlook Therapeutics Employees
Outlook Therapeutics had 23 employees as of September 30, 2024. The number of employees decreased by 1 or -4.17% compared to the previous year.
Employees
23
Change (1Y)
-1
Growth (1Y)
-4.17%
Revenue / Employee
n/a
Profits / Employee
-$3,276,814
Market Cap
55.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
OTLK News
- 4 days ago - Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug - Benzinga
- 4 days ago - Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial - GlobeNewsWire
- 12 days ago - Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment - GlobeNewsWire
- 14 days ago - Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga
- 24 days ago - Outlook Therapeutics® Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Outlook Therapeutics® Streamlines Operations - GlobeNewsWire
- 6 weeks ago - Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD - GlobeNewsWire
- 6 weeks ago - Outlook Therapeutics® Announces Executive Leadership Transition - GlobeNewsWire